Detalles de la búsqueda
1.
Whole-genome sequencing predicting phenotypic antitubercular drug resistance: meta-analysis.
J Infect Dis
; 2023 Nov 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37946558
2.
Regional differences in epidermal growth factor receptor-tyrosine kinase inhibitor therapy in lung cancer treatment using a national database in Japan.
Sci Rep
; 13(1): 5208, 2023 03 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36997606
3.
Adverse events induced by durvalumab and tremelimumab combination regimens: a systematic review and meta-analysis.
Ther Adv Med Oncol
; 15: 17588359231198453, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37720498
4.
Pembrolizumab monotherapy versus pembrolizumab plus chemotherapy in patients with non-small-cell lung cancer: A multicenter retrospective trial.
Thorac Cancer
; 13(2): 228-235, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34866339
5.
A functionally improved case of obstructive impairment caused by systemic lupus erythematosus.
Breathe (Sheff)
; 17(2): 200288, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34295418
6.
Resistance mechanisms of epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer patients: A meta-analysis.
Thorac Cancer
; 12(7): 1096-1105, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33565276
7.
T-cell response to phytohemagglutinin in the interferon-γ release assay as a potential biomarker for the response to immune checkpoint inhibitors in patients with non-small cell lung cancer.
Thorac Cancer
; 12(11): 1726-1734, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33943031
8.
Class A CpG oligodeoxynucleotide inhibits IFN-γ-induced signaling and apoptosis in lung cancer.
Thorac Cancer
; 11(4): 983-992, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32067413
9.
Identification of a novel biomarker based on lymphocyte count, albumin level, and TBAg/PHA ratio for differentiation between active and latent tuberculosis infection in Japan.
Tuberculosis (Edinb)
; 125: 101992, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32957053
10.
Identification of Biomarkers for Non-small-cell Lung Cancer Patients Treated With an Immune Checkpoint Inhibitor.
Anticancer Res
; 40(7): 3889-3896, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32620629
11.
MicroRNA-200b is a potential biomarker of the expression of PD-L1 in patients with lung cancer.
Thorac Cancer
; 11(10): 2975-2982, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32893980
12.
Afatinib + bevacizumab combination therapy in EGFR-mutant NSCLC patients with osimertinib resistance: Protocol of an open-label, phase II, multicenter, single-arm trial.
Thorac Cancer
; 11(8): 2125-2129, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32495514
Resultados
1 -
12
de 12
1
Próxima >
>>